Add BrightSurf on Google Email

High-volume antibody testing platform could accelerate disease research and treatment development

Researchers developed a high-volume method to rapidly build and test large numbers of antibodies at once, accelerating antibody research and treatment development. The oPool+ display platform has potential applications in influenza vaccination research, infectious disease treatment, and cancer research.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalScience Translational Medicine·TypeExperimental study·DateSep 3, 2025

American College of Cardiology issues vaccine guidance for adults with heart disease

The American College of Cardiology recommends flu, COVID-19, RSV vaccinations and others for adults with heart disease to reduce risks of infection, hospitalization, and death. Vaccination has been shown to be highly effective in reducing these risks, yet only 30% of primary care physicians assess patients' vaccination status.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateAug 26, 2025

Generative AI uncovers undetected bird flu exposure risks in Maryland emergency departments

A new study uses generative AI to quickly scan notes in electronic medical records and identify high-risk patients with potential H5N1 avian influenza exposure. The model detected 76 patients with high-risk exposures, including 14 confirmed cases of recent bird flu exposure.

SourceUniversity of Maryland School of Medicine·JournalClinical Infectious Diseases·TypeData/statistical analysis·DateAug 25, 2025

How does infection with respiratory syncytial virus affect the health of older adults?

A retrospective study found that older adults hospitalized with RSV experienced significantly longer hospital stays, transfers to intensive care, and 30-day mortality compared to patients with other conditions. Additionally, RSV hospitalization was associated with higher rates of heart failure and atrial fibrillation post-discharge.

SourceWiley·JournalJournal of the American Geriatrics Society·DateJul 23, 2025

H5N1 influenza viral lineages beginning to evade human immunological defenses, UNC Charlotte research finds

A new study by UNC Charlotte researchers reveals the H5N1 influenza virus is adapting to escape human immunity, increasing the risk of transmission in humans. The team's computational modeling finds a worsening trend in antibody affinity to more recent viral isolates, indicating a greater risk to human health.

SourceUniversity of North Carolina at Charlotte·JournalEBioMedicine·TypeExperimental study·DateMar 18, 2025

Study: Smartwatches could end the next pandemic

Researchers at Aalto University and others have developed a model that shows smartwatches can accurately detect viral infections several days before symptoms appear. This early detection can lead to significant reductions in disease transmission and could potentially stop a pandemic before it starts.

SourceAalto University·JournalPNAS Nexus·DateMar 4, 2025

From Spanish flu to today: how immune cells keep up with a changing virus

Researchers discovered immune cells that can recognise influenza (flu) viruses even as they mutate, providing a potential solution to the annual updates of flu vaccines. The study found that certain T cells, which play a critical role in fighting infections, can detect multiple flu strains, even those that have evolved over a century.

SourceUniversity of Melbourne·JournalScience Immunology·TypeExperimental study·DateFeb 10, 2025

Study uses game theory to rethink our pandemic responses

Dartmouth researchers propose a new way of thinking about masking and social distancing rules using game theory, considering them as two distinct actions. The study finds that people respond differently to these measures based on their perception of the disease's severity, trending towards masking or no protective action over time.

SourceDartmouth College·JournalProceedings of the National Academy of Sciences·TypeComputational simulation/modeling·DateDec 4, 2024

The molecular mechanism of Shufeng Jiedu capsules in the treatment of influenza: A comprehensive analysis based on network pharmacology, bioinformatics, and molecular docking

The study identified 97 potential therapeutic targets for SFJD, with 27 key targets involved in antiviral, anti-inflammatory, and immune regulation effects. Molecular docking results showed strong interactions between core active ingredients and these targets.

SourceXia & He Publishing Inc.·JournalFuture Integrative Medicine·DateOct 29, 2024

Applied Biological Laboratories, maker of Biovanta, to present at American Society of Microbiology’s Clinical Virology Symposium 2024

Researchers will showcase results of a randomized clinical trial demonstrating Biovanta's efficacy in reducing common cold symptoms by strengthening the respiratory barrier and controlling inflammation. The presentation will also include preclinical data on antiviral formulas targeting rhinovirus and influenza.

Child Health Day 2024: influenza vaccine protects children from infection and hospitalization for the disease, Spanish study shows

A Spanish study found that the influenza vaccination campaign for children aged 6-59 months was effective in preventing acute respiratory infections and hospitalization. The study estimated the vaccine to be 70% effective against any influenza type and 77% effective against severe cases.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeObservational study·DateOct 3, 2024

Vape residue may harm unborn babies

New research suggests that exposure to vape and e-cigarette residue on surfaces during pregnancy can cause immune system damage in unborn babies. The study found that maternal third-hand exposure to e-vapour results in significant, long-lasting effects on lung and bone marrow immune cell responses.

SourceUniversity of Technology Sydney·TypeExperimental study·DateSep 26, 2024

Sex and the flu

A team of researchers, led by Jason Shoemaker, are studying the effects of hormones on the immune system's response to the flu. Their goal is to develop targeted therapies based on a person's sex or hormone levels. The study aims to identify the molecules or pathways that affect the cells and begin to develop personalized treatments.

New two-step flu vaccine strategy shows promise in pig model

A novel two-step vaccination strategy has been developed to combat seasonal flu, pairing an intramuscular injection with a nasal spray of a weakened live-virus. The approach resulted in a strong immune response and reduced shedding of the vaccine candidate from the upper respiratory tract.

SourcePLOS·JournalPLOS Pathogens·TypeExperimental study·DateAug 8, 2024

Increased ventilation not effective in reducing influenza virus spread in play-based model, Emory study finds

A new study by Emory University researchers found that increased ventilation in childcare settings may not be effective in preventing flu virus spread. The team used a play-based model using ferrets to study the spread of flu viruses in a setting that closely mimics a childcare venue.

SourceEmory Health Sciences·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateAug 6, 2024

Study shows post-COVID conditions in primary care are comparable to flu and lower than subspecialty and hospital settings

Researchers found post-COVID conditions in primary care comparable to flu-like illnesses and lower than subspecialty and hospital settings. The study analyzed data from a national primary care registry and identified breathing difficulties, fatigue, sleep disturbances, and type 2 diabetes as common long-term health problems.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateJul 22, 2024

Think you might have COVID? Wait two days to test

A new mathematical model suggests that waiting two days after symptoms arise for rapid COVID tests can increase accuracy by reducing false negatives. The model also recommends a 'test-to-exit' strategy to prevent infections and minimize inconvenience, which may be more effective than the five-day isolation policy.

SourceUniversity of Colorado at Boulder·JournalScience Advances·TypeData/statistical analysis·DateJun 25, 2024

More hospitals than ever require staff to get flu shots

A new study reveals that 96% of VA hospitals and 74% of non-federal hospitals mandate influenza vaccination or waivers for staff. This surge is largely attributed to the 2020 Veterans Health Administration directive. The increased mandates aim to reduce flu transmission among patients, as health systems strive to improve patient safety.

SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeSurvey·DateJun 13, 2024